Market Snapshot

S&P Futures
Dow Futures
NASDAQ Futures

0.73$0.02 3.36%
At close       04:00 PM   

Stock Snapshot

0.71
Prev. Close
0.70
Open
81.60M
Market Cap
7.27M
Number of Shares
0.6831
Day Low
0.7300
Day High
0.73
-
P/E Ratio
114.94M
Free Float in %
-0.32
EPS 2021
0.40
Book Value per Share
0.20
Cash Flow per Share
Zosano Pharma Corporation (ZSAN)
Zosano Pharma Corporation (ZSAN) stock rallied over 3.36% intraday to trade at $0.73 share on NASDAQ. The stock opened with a fall of % at $0.70 and touched an intraday high of $0.7300, rising 2.82% against the last close of $0.71. The stock went to a low of $0.6831 during the session.

Historical Data

DateOpenCloseDaily HighDaily LowVolume
2021-09-10$0.68$0.69$0.70$0.68519,557
2021-09-03$0.74$0.73$0.75$0.7281,020,000
2021-09-02$0.76$0.75$0.79$0.73454,610,000
2021-09-01$0.71$0.70$0.71$0.6959,380,000
2021-08-31$0.68$0.71$0.71$0.6879,360,000
2021-08-30$0.69$0.68$0.72$0.6777,490,000
2021-08-27$0.71$0.70$0.72$0.6969,480,000
2021-08-26$0.69$0.70$0.71$0.6891,350,000
2021-08-25$0.68$0.68$0.69$0.6896,460,000
2021-08-24$0.66$0.67$0.68$0.64115,530,000
2021-08-23$0.63$0.63$0.65$0.63104,720,000
Zosano Pharma Corporation
34790 Ardentech Court
Fremont, CA 94555
United States

http://www.zosanopharma.com
510 745 1200
Employees
45
Sector
Healthcare
Sales or Revenue
700000.00
Industry
Biotechnology
5Y Sales Change
-6.50
Fiscal Year Ends
2020-12-30

Zosano Pharma Corporation
Zosano Pharma Corporation, a clinical stage biopharmaceutical company, focuses on providing therapeutics to patients suffering from migraine using its intracutaneous microneedle system. Its lead product candidate is Qtrypta (M207), a proprietary formulation of zolmitriptan used for the treatment of migraine. The company was founded in 2006 and is headquartered in Fremont, California.

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam